Indolin-2-one derivatives as protein kinase inhibitors
US8946282B2 · kind B2 · utility
2Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2013 |
| Grant date | Feb 3, 2015 |
| Priority date | — |
| Expiry date | Apr 3, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel class of indoline-2-one derivatives are disclosed. These compounds are protein kinase inhibitors which are useful for treating hyperproliferative diseases such as cancer. In one aspect, the invention relates to a compound a compound of Formula A:or a pharmaceutically acceptable salt thereof, wherein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.